Bernards Rene 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Dec 16, 2022

Insider Transaction Report

Form 4
Period: 2022-12-15
Transactions
  • Purchase

    Common Stock

    2022-12-15$0.51/sh+15,000$7,650150,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary